FDA Brief

Warning letters Devices

FDA warning letter to

Sonesta Medical AB

MediumIssued Sep 22, 2023Posted Dec 26, 2023Center for Devices and Radiological Health

FDA warned Sonesta Medical AB that its radiographic and cystometric tables violated device quality system rules.

What happened

FDA inspected Sonesta Medical AB's Solna, Sweden, facility from June 5 to June 7, 2023. FDA found inadequate procedures and records for supplier evaluation, complaint handling, design controls, and document control, and said the company's responses were incomplete.

What FDA found

  1. The company's supplier-evaluation procedure did not say how often or how much to control suppliers, contractors, and consultants, and it had not evaluated its repair servicer or QA/RA consultant.

    21 CFR 820.50(a)
  2. Its complaint procedure did not require deciding whether complaints needed Medical Device Reporting review, and complaint records lacked investigation dates and results and unique device identifier (UDI) codes.

    21 CFR 820.198(a)
  3. It had no procedure for resolving incomplete, ambiguous, or conflicting design requirements.

    21 CFR 820.30(c)
  4. Its design validation procedure did not require testing on initial production units or under actual or simulated use conditions.

    21 CFR 820.30(g)
  5. It had no procedure to control design changes, including describing changes, deciding on verification or validation, assessing risk impact, or checking new regulatory requirements.

    21 CFR 820.30(i)
  6. Its document-control procedure did not require signed and dated approval of quality documents, and many procedures lacked unique document numbers.

    21 CFR 820.40

What FDA wants

FDA asks Sonesta Medical AB to respond in writing within 15 business days with the specific corrections and corrective actions, including documentation and a timetable for any actions not finished. It also asks for retrospective reviews and English translations of non-English documents.

Who should pay attention

  • medical device manufacturers using contract servicers or consultants
  • companies that buy or distribute radiographic or cystometric tables
  • quality teams managing supplier, complaint, design, and document controls

This is a summary. Read the original letter on fda.gov.

Sonesta Medical AB's FDA history

Recalls in the last 12 months

Nov 19, 2025 Class II Sonesta Medical AB
Device
Brand Name: Sonesta Product Name: 6210 Model/Catalog Number: 0120-LA120-03 Software Version: N/A Product Description: Sonesta 6210 - Procedure table designed for full fluoroscopic imaging of the urinary tract during …
Video fluoroscopy table may contain inadequate weld on backrest bracket resulting in backrest dropping.

Full company page

Similar letters to other companies

  1. Chirp Innovations, LLC

    FDA warned Chirp Innovations over quality-system gaps, missing adverse-event reporting procedures, and unapproved marketing of its Halo muscle stimulator for menstrual pain.

    High risk
  2. Olympus Medical Systems Corporation

    FDA warns Olympus over quality-system failures across six medical device plants, including unvalidated designs and released nonconforming devices.

    High risk
  3. Linemaster Switch Corporation

    Linemaster Switch Corporation, a Connecticut maker of foot pedals for medical lasers, was cited for quality system failures after an FDA inspection.

    High risk
  4. BMC Medical Co., Ltd.

    BMC Medical’s G3X APAP devices were misbranded/adulterated after significant changes without a new 510(k) and an unreported firmware fix.

    High risk